/
Other
Adult
127
Pipeline Programs↗
123
Active Trials↗
260
Companies Involved↗
Adult is a highly competitive landscape with 127 programs across 260 companies. The most active players are Pfizer, Changchun GeneScience Pharmaceutical Co., Ltd., Biogen. 6 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical16
Phase 195
Phase 210
Phase 36
Approved
No programs
Analysis
Modality Breakdown
99%
Small molecule
113 of 114 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 114 classified programs, each share of the total. Modality classified for 100% of 127 pipeline programs.
Analysis
Trial Status
1,182
clinical trials
Completed938 · 79%
Recruiting62 · 5%
Terminated49 · 4%
Unknown status45 · 4%
Not yet recruiting32 · 3%
Withdrawn25 · 2%
Other31 · 3%
Clinical Trials
Trial Activity
1182 trials
Page 1 of 79
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)